Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Proposers' Day

Active

ARPA-H-SN-26-160Federal

Response Deadline09/04/2026, 04:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)View Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

DC, 20005, USA

Set-Aside

NONE

Documents

(1)

ARPA-H-SN-26-160_FASTPASS_Proposers_Day.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PostedAug 20

special-notice

Response DeadlineSep 4

Submission deadline

Response Deadline

09/04/2026, 04:00:00 PM UTCin 14 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Contacts1 person available

OfficeWashington, DC, 20005, USA

Organization / Agency

Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

View Agency Profile

Office AddressWashington, DC, 20005, USA

Contacts

The FASTPASS Team

contact@example.gov

Full Description

Show more

The Scalable Solutions Office (SSO) of the Advanced Research Projects Agency for Health (ARPA-H) is hosting a Proposers’ Day in support of the Innovative Solutions Opening (ISO) for the Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, And SupplieS (FASTPASS) program. The FASTPASS Proposers’ Day will be a one-day hybrid event on Thursday, September 10, 2026, 9:00am-5:00pm Eastern Time (ET).

See Special Notice: ARPA-H-SN-26-160 (attached) for further details.

Similar Contracts

Same NAICS industry code

Mobile Integrated Launch Capability

Solicitation # 26-MDA-12366

The Missile Defense Agency (MDA) is seeking industry partners to develop a Mobile Integrated Launch Capability (MILC) to replace or augment current air-drop C-17 target launch systems through a two-phase contract effort. Phase I focuses on detailed design, engagement analysis, and cost estimation for candidate concepts, while Phase II involves prototyping, ground testing, and live launch of a selected target system from a global location. Proposals must demonstrate an innovative, novel approach with high execution potential, strong alignment with MDA’s mission objectives, and a fast-paced schedule that enables frequent testing, all while maintaining low lifecycle costs. Offerors are required to submit a white paper not exceeding ten pages in a specific format with sections including an executive summary, program description, milestone chart, prior work, and a Rough Order of Magnitude. White papers may be submitted at Unclassified, Controlled Unclassified Information (CUI), or Secret levels, with strict handling protocols for CUI and Secret materials, including banner and portion markings and restricted distribution statements like FEDONLY or FEDCON. Secure submissions must use approved channels including SIPRnet, courier, or hard copy only; electronic files must be unzipped, unpassworded, and under 10MB for unclassified submissions. Contract performance will require an active Secret Facility Clearance Level and compliance with Secret safeguarding standards, as verified by MDA prior to award. Offerors must also disclose any Organizational Conflicts of Interest using the MDA Form DA-78-F2, and adhere to FAR and DFARS provisions regarding procurement integrity, cybersecurity (NIST SP 800-171, CMMC), export controls (ITAR/EAR), and government rights in technical data. The contract may be awarded as a fixed-price, cost-reimbursement, or Other Transaction Agreement, with selection based on a trade-off evaluation emphasizing technical merit and strategic value over lowest cost. Performance periods are set at up to six months for Phase I and twenty-four months for Phase II, though objectives are 3 and 12 months respectively. All work will be performed with the primary point of performance at Redstone Arsenal, Alabama, though launch operations are designed for global deployment. No formal packaging, preservation, or physical item marking standards are specified, though use of COTS/GOTS components and open architecture is required. The solicitation remains open with no firm deadline, accepting submissions continuously via email until further notice, with offerors responsible for maintaining active SAM registration, providing updated UEI

Missile Defense Agency (mda)

POSTED

about 7 hours ago

DEADLINE

in about 2 years

Area of Interest: OSW Cost Assessment and Program Evaluation (CAPE) Business Process Modernization

Solicitation # HQ003426AOI04

The Washington Headquarters Services, on behalf of the Department of War Cost Assessment and Program Evaluation, is seeking a novel business process solution to prototype a modernized replacement for its current bespoke business operations workflow platforms and databases. The objective is to implement a comprehensive system that integrates personnel management for civilians, military, and contractors, budget formulation and expenditure tracking, and advanced workflow tools for custom and standard coordination actions. The desired solution must offer a refreshed user interface, streamlined data sharing, and the ability to dynamically evolve without causing system failures. The required system must integrate with existing enterprise systems such as iCompass, DCPDS, DAI, and DISS, while maintaining certification for NIPRnet and DoDNet. It must securely handle PII and IL5 information based on user roles and comply with all records management requirements. This effort is being conducted under Commercial Solutions Opening procedures and is open to teaming arrangements utilizing integrated commercial products. Interested parties must adhere to the specific instructions detailed in the CSO and monitor for amendments via sam.gov.

Washington Headquarters Services

POSTED

about 7 hours ago

DEADLINE

Environmental Security Technology Certification Program (ESTCP) – Energy and Environmental Technology Demonstrations – Open Topics BAA

Solicitation # W912HQ26S0051

POSTED

about 7 hours ago

DEADLINE

Strategic Environmental Research and Development Program (SERDP) – Open Topics Broad Agency Announcement (BAA)

Solicitation # W912HQ26S0050

POSTED

about 7 hours ago

DEADLINE

Geosciences Core Research: Atmospheric, Geospace, Earth and Ocean Sciences (GEO Core)

Solicitation # 26-516

The National Science Foundation is seeking proposals under solicitation 26-516 for the Geosciences Research program, also known as GEO Core. This federal initiative supports foundational research aimed at advancing scientific knowledge across three primary programs: Atmospheric and Geospace Sciences, Earth Sciences, and Ocean Sciences. The agency is specifically interested in intellectually ambitious and transformative research regarding the Earth's atmosphere, near-Earth space, solid Earth sciences, surface processes, and all fields of ocean science. Competitive proposals may focus on a single domain or span multiple disciplines and are not required to provide near-term commercial outcomes or specific product deployments. Interested parties must submit their responses by the deadline of August 14, 2026. All inquiries and submissions are managed through the U.S. National Science Foundation.

National Science Foundation

POSTED

about 15 hours ago

DEADLINE

in almost 50 years

Project Griffin: Intelligent Response and Orchestration Node

Solicitation # CPEISW-CFS-26-001

POSTED

DEADLINE

Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening

Solicitation # ARPA-H-SOL-26-160

Advanced Research Projects Agency For Health (arpa-H)

POSTED

DEADLINE

Solicitation # W911NF26S0040

The Department of Defense, through the Transformation and Training Command (T2COM) and the Army Applications Laboratory (AAL), has issued a long-term, open call solicitation titled "DevX Autonomy" to seek advanced technology solutions related to autonomy and unmanned systems. This effort aims to support research, development, testing, procurement, and sustainment of both hardware and software solutions that enhance autonomous unmanned system capabilities. The solicitation, governed by DFARS regulations, specifically targets proposals that address capability gaps, meet requirements, or push the state of the art in autonomy technology. Submitted solutions will be evaluated and potentially integrated via rapid acquisition pathways to expedite deployment. The solicitation number for this combined type contract is W911NF26S0040, posted on December 23, 2025, with a response deadline of July 31, 2026. It falls under NAICS code 541715 and is managed by the Department of Defense office located in Research Triangle Park, North Carolina. The primary place of performance is Austin, Texas. Interested parties can direct inquiries and submissions to the DevX Autonomy email contact provided by the Army Applications Laboratory. Further details and documentation are accessible through the official government contracting website.

W6QK Acc-Apg Durham

POSTED

DEADLINE

Optical Engineering and Optomechanical Engineering Services RFI

Solicitation # SG-2650-07302026

The Jet Propulsion Laboratory is seeking information from qualified vendors capable of providing comprehensive Optical Engineering and Optomechanical Engineering services to support a diverse portfolio of advanced space instruments, including off-axis reflective telescopes, cryogenic imaging systems, hyperspectral imagers, and multiband systems. Vendors must demonstrate expertise across the full engineering life cycle, including high-level optical design and modeling, complex optomechanical hardware development, Structural Thermal Optical Performance analysis, automated test equipment, and hands-on cleanroom integration, precision alignment, and verification. Due to the sensitive nature of some projects, partners must be able to operate effectively in both unclassified environments and on highly classified missions requiring TS/SCI clearance, demonstrating institutional flexibility to manage mixed classification workloads. The work also involves building multiple identical flight systems, necessitating close collaboration with JPL personnel to transfer and institutionalize proprietary alignment and test methodologies. Responses are required by 3:00 PM Pacific Time on August 21, 2026, and will be used solely for planning purposes to assess potential sources and determine eligibility for future procurements, including potential Small Business Set-Asides under NAICS code 541715 with a size standard of 1,000 employees. All submitted information will be treated as provided with unlimited rights to JPL, which assumes no liability for its use, disclosure, or reproduction. The contracting office is located in Pasadena, California, and all submissions must be sent electronically to Shannon Grover, JPL Subcontracts Manager. This RFI does not represent a solicitation or obligation to award any contract, and respondents bear all costs associated with their submissions.

NASA Management Office -- Jpl

POSTED

DEADLINE

in about 3 hours

HADES (Hybrid Architecture and Development for Experimental Systems) Request for Proposal

Solicitation # FA8809-26-R-B002

The Hybrid Architecture and Development for Experimental Systems (HADES) contract, identified by solicitation FA8809-26-R-B002, is an indefinite-delivery, indefinite-quantity (IDIQ) vehicle issued by the Space Systems Command’s Innovation and Prototyping Delta at Kirtland Air Force Base, New Mexico. The base ordering period spans three years from February 2027 through February 2030, with four one-year option periods available, potentially extending performance through February 2034. The contract supports satellite ground system engineering, development, integration, and sustainment services, primarily at the Research, Development, Test, and Evaluation Support Complex (RSC) at Kirtland AFB, utilizing a mix of Cost-Reimbursable with Cost-Plus-Award-Fee, Firm-Fixed-Price, and Cost-type contract line items. All personnel must hold at least a Secret clearance, with many roles requiring Top Secret/Sensitive Compartmented Information (TS/SCI) eligibility due to the classified nature of the RSC environment and mission-critical operations. The contract is structured around task orders issued during the ordering period, with pricing determined at the task order level and structured to comply with fiscal law requirements, including annual pricing as outlined in Section L Appendix A and Section M Table 27. The technical evaluation criteria are prioritized in a strict hierarchy: Technical > Past Performance > Cost/Price, with no numerical weights applied. The Technical factor, which is the most critical, has been refined into five subfactors: Program Management Administrative Requirements (Pass/Fail), Program Management Staffing/Labor Profile (Adjectival), Program Management Emerging Requirements Response (Adjectival and the primary discriminator), Systems Engineering Approach and Methodology (Adjectival), and Systems Engineering Configuration Management (Pass/Fail). The Emerging Requirements Response subfactor serves as the key differentiator among proposals. Past Performance will be assessed holistically for confidence in successful execution, while Cost/Price is evaluated for reasonableness and consistency but considered least important in the trade-off. Offerors must submit proposals in five volumes with strict page limits, excluding certain front matter from counts. The evaluation is a best-value trade-off, not a lowest-price, technically acceptable approach. Section L imposes significant requirements including a mandatory OCI Mitigation Plan, compliance with DoD cybersecurity standards via NIST SP 800-171, implementation of a Small Business Subcontracting Plan, and workforce constraints including a maximum of

FA8809 Sda And Cmbt Pwr Ssc/szk-Ik

POSTED

DEADLINE

RFI for Next Generation Hypersonic Cruise Missiles

Solicitation # DARPA-SN-26-93

The U.S. Defense Advanced Research Projects Agency is seeking industry input through a Request for Information to shape the future acquisition strategy for a potential program focused on next-generation hypersonic cruise missiles. This RFI, issued under solicitation number DARPA-SN-26-93 and posted on August 7, 2026, with responses due by October 6, 2026, aims to refine technical specifications, validate programmatic assumptions, and guide the development of a competitive solicitation. The agency is particularly interested in fostering innovative partnerships between traditional defense contractors, non-traditional industry players, technology developers, and specialized test and evaluation providers to advance capabilities in this high-priority domain. Responses will directly inform DARPA’s understanding of current industry capabilities and potential pathways for innovation. The effort falls under NAICS code 541715, indicating a focus on research and development in the physical, engineering, and life sciences. All submissions must be directed to the TTO Acquisition Team at DARPA-SN-26-93@darpa.mil, and no set-aside status is anticipated, meaning the opportunity is open to all eligible entities regardless of size or status. The office is located in Arlington, Virginia, and while the place of performance has not been specified, the program is expected to involve nationwide collaboration and testing. This RFI serves as a precursor to a future formal solicitation, positioning industry to align its capabilities with DARPA’s strategic goals in hypersonic systems and to position itself for upcoming contract opportunities.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

in about 2 months

Long Range BAA for the Undersea Security Program

Solicitation # N00030-23-S-7002

The Strategic Systems Programs (SSP), part of the Department of the Navy, is inviting proposals for Long-Range Science and Technology (S&T) Projects to support its Undersea Security Program. The goal is to competitively fund high-potential research across a variety of science and engineering fields relevant to undersea security initiatives. This announcement serves as the second annual update to the Broad Agency Announcement (BAA), originally issued under solicitation number N00030-23-S-7002, with the latest version being N00030-25-S-7002. Applicants are advised to review all updates and changes, which are clearly marked in red within the BAA and its appendices. The current solicitation was posted on August 7, 2025, and has a response deadline of August 11, 2026. The applicable NAICS code is 541715, indicating a focus on Research and Development in the Physical, Engineering, and Life Sciences (except nanotechnology and biotechnology). Interested parties can reach out to the primary point of contact, David Shriner, for further information. The contracting office is located at the Washington Navy Yard in Washington, DC. Proposals should aim to advance the technological capabilities of the Undersea Security Program and align with the Department of the Navy's long-term security objectives.

Pae Strategic Systems Programs

POSTED

DEADLINE

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

Advanced Research Projects Agency for Health (ARPA-H) Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Program

Solicitation # 7599226SN106

The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals through a Broad Agency Announcement for its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, targeting small business concerns with expertise in innovative biomedical and health technologies. Eligible small businesses must be organized for profit, headquartered and primarily operating in the United States, and have no more than 500 employees, including affiliates, with majority ownership held by U.S. citizens or permanent residents. Alternatively, ownership may be held by multiple venture capital, hedge fund, or private equity firms, provided no single entity owns more than 50% of the concern. Proposers must be registered in SAM.gov with a Unique Entity Identifier and must also be certified in the SBA Company Registry. The solicitation is a Total Small Business Set-Aside under FAR 19.5, with NAICS code 541715, and all submissions must be made via the ARPA-H Solutions site. A critical deadline for Stage 1 Solution Summaries has been extended to July 17, 2026, and all proposals must include required documentation such as the Solution Summary Template, SBA Proof of Registration, Funding Agreement Certification, Foreign Disclosure Form, and VCOC Certification where applicable. Compliance with federal statutes, regulations, and security requirements, including the FAR 52.240-91 Security Prohibitions and Exclusions clause, is mandatory. The solicitation outlines seven open research topics, each targeting high-impact, high-risk innovations in women’s health, surgical adhesion, synthetic biology, endometriosis treatment, ARPA-H technology transition, autoimmune diagnostics, and neurosurgical robotics. Proposals must detail technical approaches, innovation, feasibility, and a clear path to commercialization and patient health outcomes. Evaluation is based on pass/fail gates for SBC eligibility and security risk via the HHS Due Diligence Program, followed by technical merit, novelty, team experience, and potential health impact. A fixed milestone-based payment structure applies, with Phase I awards typically lasting one year and disbursed in six installments tied to deliverables such as kickoff presentations, quarterly reports, draft and final reports, commercialization updates, invention disclosures, and lifecycle certifications. Required deliverables include a Task Description Document, GANTT chart, and detailed cost proposal using the official templates, with costs evaluated for reasonableness relative to scope. Proposers must mark proprietary information appropriately, bear all

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Pharmaceutical Supply and Dosing Strategy SupportThe contract pertains to the formulation, stability testing, and supply chain management of ibogaine or closely related compounds under an Investigational New Drug application to support clinical research initiatives. It requires the secure and compliant production of precise dosing formulations, adherence to rigorous pharmaceutical standards for compound stability, and robust logistics to ensure uninterrupted delivery of materials to authorized research sites. All activities must align with federal regulatory requirements governing investigational substances and be executed within a tightly controlled framework to maintain quality, safety, and chain-of-custody integrity throughout the supply lifecycle. The work is being solicited as a subcontract under the Advanced Research Projects Agency for Health, a division of the Department of Health and Human Services, with a primary focus on accelerating innovative therapeutic development. The solicitation is open for responses until October 15, 2026, and the North American Industry Classification System code 325412 indicates the scope involves pharmaceutical preparations manufacturing. Performance is expected to meet stringent federal standards for investigational drug supply, with no geographical restrictions specified on place of performance, allowing for flexible, secure, and scalable logistical execution across approved facilities.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

in about 2 months

Phase III Clinical Development and Regulatory Transition PlanningThe contract titled Phase III Clinical Development and Regulatory Transition Planning focuses on strategic guidance for advancing a therapeutic or medical product from Phase II to Phase III clinical trials. It requires a detailed analysis of the regulatory pathway to ensure compliance with current and anticipated requirements from health authorities, as well as development of a long-term roadmap that integrates clinical, manufacturing, and commercialization goals. The work must account for global regulatory harmonization, risk mitigation strategies, and feasibility assessments for large-scale trial design and patient recruitment. This is a subcontract under the Advanced Research Projects Agency for Health, part of the Department of Health and Human Services, with a NAICS code of 541620 indicating management, scientific, and technical consulting services. The opportunity was posted on August 5, 2026, with a response deadline of October 15, 2026. There is no set-aside designation specified, and the place of performance is not defined, allowing flexibility in where the work is conducted. The contract emphasizes expert-level planning to de-risk the transition to pivotal trials and secure regulatory alignment for future approval and market access.

Environmental Consulting Services

POSTED

DEADLINE

in about 2 months

Operational Execution of Multi-Site Clinical TrialsThe contract titled Operational Execution of Multi-Site Clinical Trials entails the comprehensive management and coordination of clinical trial operations across multiple geographic locations, with core responsibilities including the training and oversight of clinical staff, the implementation of patient recruitment strategies, and the accurate and timely collection of trial data. The scope demands a robust operational framework to ensure protocol adherence, regulatory compliance, and data integrity across all participating sites, requiring experienced personnel with demonstrated expertise in decentralized and multi-site clinical research environments. Issued as a subcontract under the Advanced Research Projects Agency for Health part of the Department of Health and Human Services, this opportunity is governed by NAICS code 541611 and requires proposals to be submitted by October 15, 2026. While the solicitation number and specific address details are not provided, performance is expected to occur across unspecified locations, indicating a nationwide or potentially international operational footprint. The contracting entity seeks entities capable of delivering scalable, efficient, and compliant clinical trial execution without direct oversight, emphasizing autonomy, quality control, and responsiveness in complex, distributed study settings.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

in about 2 months

Therapeutic Set and Setting Protocol DevelopmentThe contract seeks the development of a comprehensive therapeutic set and setting protocol for the administration of ibogaine, focusing on the design of a safe, supportive, and clinically rigorous environment that optimizes patient outcomes. This includes the creation of structured psychological support systems, detailed patient preparation procedures, and integrated post-treatment protocols to ensure continuity of care and long-term therapeutic benefit. The protocol must be grounded in evidence-based practices and tailored to address the unique physiological and psychological demands of ibogaine therapy, with an emphasis on harm reduction, informed consent, and ethical standards. The work is being procured as a subcontract under the Advanced Research Projects Agency for Health, part of the Department of Health and Human Services, with a submission deadline of October 15, 2026. The project falls under NAICS code 621399, reflecting its focus on specialized medical services involving non-traditional therapeutic modalities. While the place of performance and point of contact details are not specified, the initiative aims to advance clinical frameworks for psychedelic-assisted therapies and requires a multidisciplinary approach integrating medical, psychological, and environmental design elements. Success will depend on delivering a replicable, scalable model that meets federal standards for safety, efficacy, and patient-centered care.

Offices of All Other Miscellaneous Health Practitioners

POSTED

DEADLINE

in about 2 months

Clinical Trial Safety and Risk Mitigation PlanningThe contract pertains to the development of comprehensive safety protocols for ibogaine clinical trials, with a focus on mitigating risks associated with its use in therapeutic settings. Key components include the implementation of rigorous cardiotoxicity monitoring systems to detect and manage potential cardiac adverse events, detailed assessments of drug interactions to prevent harmful combinations, and the establishment of dose de-escalation strategies to ensure patient safety across varying treatment phases. These protocols are intended to support the responsible and scientifically sound advancement of ibogaine research, particularly in contexts where safety concerns have historically hindered clinical progress. This subcontract is issued under the auspices of the Advanced Research Projects Agency for Health, a division of the Department of Health and Human Services, reflecting a federal commitment to advancing innovative but high-risk therapeutic modalities. The work is to be completed in response to a solicitation posted on August 5, 2026, with proposals due by October 15, 2026. The NAICS code 541690 indicates the nature of the work involves other scientific and technical consulting services, aligning with the specialized expertise required for designing and validating complex clinical safety frameworks. The place of performance and point of contact details are unspecified, suggesting flexibility in execution location while maintaining strict adherence to federal safety and compliance standards.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

in about 2 months

Integrated Phase I/II Clinical Trial DesignThe contract seeks the design and protocol development for an integrated Phase I/II clinical trial to evaluate ibogaine as a potential treatment for opioid use disorder, focusing on safety, optimal dosing, and therapeutic efficacy. The effort requires a comprehensive clinical framework that seamlessly merges the objectives of Phase I, which prioritizes dose escalation and toxicity profiling, with those of Phase II, which assesses preliminary effectiveness in reducing opioid dependence and withdrawal symptoms. The protocol must adhere to rigorous scientific and regulatory standards, incorporating appropriate patient selection criteria, monitoring procedures, endpoints, and risk mitigation strategies for a substance with significant pharmacological and safety considerations. The work is being pursued as a subcontract under the Advanced Research Projects Agency for Health, part of the Department of Health and Human Services, with a NAICS code indicating research and development in the life sciences. The solicitation was posted on August 5, 2026, and responses are due by October 15, 2026. The project is situated within a broader initiative to advance novel therapeutic interventions for the opioid crisis, requiring innovative trial design that balances exploratory research with clinical feasibility. There is no specified set-aside designation or location restriction for performance, indicating flexibility in execution while emphasizing scientific merit and regulatory alignment as key evaluation criteria.

Research and Development in Biotechnology

POSTED

DEADLINE

in about 2 months

Area of Interest under PHO ISO: ASCENT-IBO

Solicitation # ARPA-H-SN-26-158

The Advanced Research Projects Agency for Health (ARPA-H) is issuing a special notice to solicit proposals for the ASCENT-IBO initiative, aimed at accelerating the safe clinical evaluation of ibogaine as a treatment for opioid use disorder. This effort builds on prior guidance and seeks innovative approaches to rapidly advance novel therapeutics through rigorous, scalable, and ethically sound clinical pathways. Applications must be submitted by October 15, 2026, and the opportunity is open to organizations with expertise in clinical research, pharmacology, and addiction medicine under NAICS code 541715. The office managing this solicitation is located in Washington, DC, and while no specific performance location is defined, proposers must demonstrate capacity to execute multi-site clinical activities. A Proposers’ Day event is planned to provide further context and foster collaboration among potential applicants. The primary point of contact is listed in the description section, with a designated email provided that should not be used for inquiries. All submissions must align with ARPA-H’s mission to drive high-impact, transformative health solutions.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

in about 2 months

Technology InteGrator and AcceleratoR (TIGAR)

Solicitation # ARPA-H-SOL-26-144

The Technology InteGrator and AcceleratoR (TIGAR) solicitation, issued by the Advanced Research Projects Agency for Health (ARPA-H) under number ARPA-H-SOL-26-144, seeks innovative solutions to enable temperature-flexible storage of complex regenerative tissues and organs, removing reliance on strictly controlled cryogenic conditions. The effort targets functional preservation of organoids, donated tissues, whole organs, or one-cubic-centimeter tissue volumes for at least 30 days at practical temperatures: -80°C, -20°C, 4°C, or 20°C–25°C room temperature, using novel combinations of materials, AI/ML, high-throughput screening, biological interventions, devices, or packaging approaches. The project is structured as an 18-month period of performance divided into two nine-month phases, with a down-select decision at the end of Phase 1. Proposals must align with HHS health IT standards, promote open-source software licensing (MIT, BSD, Apache 2.0), enhance data interoperability, and avoid low-risk or junior-staffed approaches designed solely for cost appearance. Funding is capped at $2 million per award, and only proposals submitted through the ARPA-H Solution Submission Portal will be considered. The solicitation allows multiple Other Transaction (OT) agreements and does not use a set-aside. Submission follows a two-step process: first, a 7-minute Solution Video with a transcript and supplemental slides, and second, a Full Proposal including technical, management, cost, and administrative documentation. The Solution Video deadline for Intake Group 1 has been amended to August 12, 2026, with the Full Proposal deadline extended to September 17, 2026; Intake Group 2 deadlines remain December 8, 2026, and February 5, 2027, respectively. All materials must be submitted via the ARPA-H portal, in English, using sans-serif 11-point fonts, with file names free of spaces or symbols. Evaluation prioritizes scientific and technical merit, proposer capabilities, alignment with ARPA-H’s mission and user needs, and cost realism. Proposal teams must hold valid SAM.gov registrations with active UEIs, provide good faith representations of intellectual property ownership, disclose organizational conflicts of interest, and ensure compliance with federal research security regulations, including prohibitions against involvement with malign foreign talent programs or entities of concern under the CHIPS and

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

Brain Repair of Any Injured Neural Structure (BRAINS)

Solicitation # ARPA-H-SOL-26-148

The Advanced Research Projects Agency for Health (ARPA-H) is seeking innovative solutions through the Brain Repair of Any Injured Neural Structure (BRAINS) Exploratory Topic program under solicitation ARPA-H-SOL-26-148, which utilizes Other Transaction (OT) agreements rather than standard federal contract mechanisms. The program aims to advance technologies capable of restoring function to damaged brain regions—specifically targeting areas such as the hippocampus, amygdala, thalamus, hypothalamus, striatum, cingulate cortex, substantia nigra, brainstem, and cerebellum—by generating and engrafting region-specific precursor tissue, while explicitly excluding the neocortex and spinal cord as well as conventional cell or organoid-based approaches. Proposers must submit a mandatory solution summary prior to full proposal submission, with two intake cycles: the first requiring solution summaries by July 9, 2026, and full proposals by August 6, 2026; the second, with deadlines of January 7, 2027, and February 6, 2027, respectively. Proposals must be submitted via the ARPA-H Solution Submission Portal and must conform to a strict three-volume structure: Volume I (Technical and Management Proposal with a 10-page limit for core content), Volume II (Cost Proposal using the ARPA-H Standard Excel Spreadsheet and supporting narrative), and Volume III (Administrative and Policy Requirements including certifications for organizational conflicts of interest, research security, biosecurity, cyber practices, animal research approvals, and tax compliance). Awardees will be evaluated based on the scientific and technical merit of the approach, the proposer’s expertise, potential for clinical and commercial impact aligned with ARPA-H’s mission, and the reasonableness of the proposed cost, with no preset weighting but ranked in descending importance. Phase I awards are anticipated at $500,000 per team with optional Phase II funding up to an additional $500,000, subject to successful technical milestones and budgetary compliance. Financial administration requires registration and invoice submission via the Payment Management Services (PMS) portal, with detailed justifications for each payment tied to specific milestones or TDD tasks, and salary support for individuals is capped at the Executive Level II rate set by the Office of Personnel Management. All awarded work must occur in the United States, with priority given to domestic entities, and proposers must confirm compliance with national security

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 2 months ago

DEADLINE

Transition Readiness & Exportable Data SolutionsThe contract focuses on the development of open standards, exportable data formats, and comprehensive transition plans aimed at ensuring future competition and vendor neutrality for the AURORA platform. It involves creating solutions that facilitate interoperability and data portability to prevent vendor lock-in and support a competitive ecosystem. The work is designed to promote sustainable technology adoption and flexibility within the platform's evolving infrastructure. Issued as a subcontract under the Advanced Research Projects Agency for Health (ARPA-H), part of the Department of Health and Human Services, the contract is linked to activities performed in Washington, ZIP code 20005. The associated NAICS code is 541611, which corresponds to administrative management and general management consulting services. This initiative reflects a strategic approach to health technology development, emphasizing readiness for transition and broad data accessibility to enhance innovation and collaboration across stakeholders.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE